Perindopril versus captopril: Efficacy and acceptability in an Italian multicenter trial

E. Agabiti-Rosei, E. Ambrosioni, G. Finardi, P. Folino, G. Gambassi, P. Malini, E. Marchesi, M. L. Muiesan, A. Semplicini, A. C. Pessina

Research output: Contribution to journalArticle

Abstract

The aim of this 3-month, double-blind, double-dummy, parallel group study was to compare the antihypertensive efficacy and acceptability of perindopril (4-8 mg/day) in 54 patients (30 males, 24 females, 25-68 years of age) and captopril (50-100 mg/day) in 54 patients (39 males, 15 females, 29-66 years of age) in the treatment of essential hypertension. In a subgroup of 38 patients a complete echocardiographic study was performed. The two groups had similar (ANOVA) blood pressure (BP), heart rate (HR), body mass index, and duration of hypertension. Supine and standing BP was significantly reduced by both drugs, without differences between them. Owing to poor control of BP, hydrochlorothiazide (25 mg/day) was added to 27% of patients on perindopril and to 41% of patients on captopril (p

Original languageEnglish
JournalAmerican Journal of Medicine
Volume92
Issue number4 B
Publication statusPublished - 1992

Fingerprint

Perindopril
Captopril
Multicenter Studies
Blood Pressure
Hydrochlorothiazide
Antihypertensive Agents
Analysis of Variance
Body Mass Index
Heart Rate
Hypertension
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Agabiti-Rosei, E., Ambrosioni, E., Finardi, G., Folino, P., Gambassi, G., Malini, P., ... Pessina, A. C. (1992). Perindopril versus captopril: Efficacy and acceptability in an Italian multicenter trial. American Journal of Medicine, 92(4 B).

Perindopril versus captopril : Efficacy and acceptability in an Italian multicenter trial. / Agabiti-Rosei, E.; Ambrosioni, E.; Finardi, G.; Folino, P.; Gambassi, G.; Malini, P.; Marchesi, E.; Muiesan, M. L.; Semplicini, A.; Pessina, A. C.

In: American Journal of Medicine, Vol. 92, No. 4 B, 1992.

Research output: Contribution to journalArticle

Agabiti-Rosei, E, Ambrosioni, E, Finardi, G, Folino, P, Gambassi, G, Malini, P, Marchesi, E, Muiesan, ML, Semplicini, A & Pessina, AC 1992, 'Perindopril versus captopril: Efficacy and acceptability in an Italian multicenter trial', American Journal of Medicine, vol. 92, no. 4 B.
Agabiti-Rosei E, Ambrosioni E, Finardi G, Folino P, Gambassi G, Malini P et al. Perindopril versus captopril: Efficacy and acceptability in an Italian multicenter trial. American Journal of Medicine. 1992;92(4 B).
Agabiti-Rosei, E. ; Ambrosioni, E. ; Finardi, G. ; Folino, P. ; Gambassi, G. ; Malini, P. ; Marchesi, E. ; Muiesan, M. L. ; Semplicini, A. ; Pessina, A. C. / Perindopril versus captopril : Efficacy and acceptability in an Italian multicenter trial. In: American Journal of Medicine. 1992 ; Vol. 92, No. 4 B.
@article{4fe71d518f684de697daddd7431576f7,
title = "Perindopril versus captopril: Efficacy and acceptability in an Italian multicenter trial",
abstract = "The aim of this 3-month, double-blind, double-dummy, parallel group study was to compare the antihypertensive efficacy and acceptability of perindopril (4-8 mg/day) in 54 patients (30 males, 24 females, 25-68 years of age) and captopril (50-100 mg/day) in 54 patients (39 males, 15 females, 29-66 years of age) in the treatment of essential hypertension. In a subgroup of 38 patients a complete echocardiographic study was performed. The two groups had similar (ANOVA) blood pressure (BP), heart rate (HR), body mass index, and duration of hypertension. Supine and standing BP was significantly reduced by both drugs, without differences between them. Owing to poor control of BP, hydrochlorothiazide (25 mg/day) was added to 27{\%} of patients on perindopril and to 41{\%} of patients on captopril (p",
author = "E. Agabiti-Rosei and E. Ambrosioni and G. Finardi and P. Folino and G. Gambassi and P. Malini and E. Marchesi and Muiesan, {M. L.} and A. Semplicini and Pessina, {A. C.}",
year = "1992",
language = "English",
volume = "92",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "4 B",

}

TY - JOUR

T1 - Perindopril versus captopril

T2 - Efficacy and acceptability in an Italian multicenter trial

AU - Agabiti-Rosei, E.

AU - Ambrosioni, E.

AU - Finardi, G.

AU - Folino, P.

AU - Gambassi, G.

AU - Malini, P.

AU - Marchesi, E.

AU - Muiesan, M. L.

AU - Semplicini, A.

AU - Pessina, A. C.

PY - 1992

Y1 - 1992

N2 - The aim of this 3-month, double-blind, double-dummy, parallel group study was to compare the antihypertensive efficacy and acceptability of perindopril (4-8 mg/day) in 54 patients (30 males, 24 females, 25-68 years of age) and captopril (50-100 mg/day) in 54 patients (39 males, 15 females, 29-66 years of age) in the treatment of essential hypertension. In a subgroup of 38 patients a complete echocardiographic study was performed. The two groups had similar (ANOVA) blood pressure (BP), heart rate (HR), body mass index, and duration of hypertension. Supine and standing BP was significantly reduced by both drugs, without differences between them. Owing to poor control of BP, hydrochlorothiazide (25 mg/day) was added to 27% of patients on perindopril and to 41% of patients on captopril (p

AB - The aim of this 3-month, double-blind, double-dummy, parallel group study was to compare the antihypertensive efficacy and acceptability of perindopril (4-8 mg/day) in 54 patients (30 males, 24 females, 25-68 years of age) and captopril (50-100 mg/day) in 54 patients (39 males, 15 females, 29-66 years of age) in the treatment of essential hypertension. In a subgroup of 38 patients a complete echocardiographic study was performed. The two groups had similar (ANOVA) blood pressure (BP), heart rate (HR), body mass index, and duration of hypertension. Supine and standing BP was significantly reduced by both drugs, without differences between them. Owing to poor control of BP, hydrochlorothiazide (25 mg/day) was added to 27% of patients on perindopril and to 41% of patients on captopril (p

UR - http://www.scopus.com/inward/record.url?scp=17344381818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17344381818&partnerID=8YFLogxK

M3 - Article

C2 - 1580285

VL - 92

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 4 B

ER -